Has Richard Linsk received payments from drug or device companies?

Yes. Drug and device makers reported $2,181 in general payments to Richard Linsk across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Linsk did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Linsk come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Linsk

Psychiatry · Roanoke, VANPI 1356355580

Payments from drug & device makers

$2,181in general payments, 2019–2025

Across 101 payments — averaging $21.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$421
Vanda Pharmaceuticals Inc.$230
E.r. Squibb & Sons, L.L.C.$208
Johnson & Johnson$178
Tris Pharma Inc$174
Axsome Therapeutics, Inc.$153
plus $817 from 11 others

What the payments were for

Food & beverage$2,181100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	25	$421
Vanda Pharmaceuticals Inc.	10	$230
E.r. Squibb & Sons, L.L.C.	10	$208
Johnson & Johnson	7	$178
Tris Pharma Inc	4	$174
Axsome Therapeutics, Inc.	6	$153
Neurocrine Biosciences, Inc.	6	$148
Alkermes, Inc.	6	$114
Supernus Pharmaceuticals, Inc.	6	$112
Sunovion Pharmaceuticals Inc.	1	$106
Teva Pharmaceuticals USA, Inc.	5	$93
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$65
Neos Therapeutics, LP	4	$52
Indivior Inc.	2	$42
Lundbeck LLC	2	$34
Avanir Pharmaceuticals, Inc.	2	$29
Shire North American Group Inc	2	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,181 in reported general payments places this provider in the 80th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Abilify MaintenaAripiprazole	14	$42,657
Invega SustennaPaliperidone Palmitate	14	$32,453
VraylarCariprazine Hcl	11	$16,838
Lurasidone Hcl	24	$4,961
Bupropion XlBupropion Hcl	108	$4,277
Paliperidone ErPaliperidone	31	$4,236
Olanzapine	38	$1,938
Vilazodone Hcl	29	$1,767
Leucovorin Calcium	11	$1,675
Doxazosin Mesylate	108	$1,160
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	24	$1,082
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	31	$1,052
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	25	$1,003
Oxcarbazepine	37	$988
Buspirone Hcl	38	$959

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena	$421	$42,65714 claims
Johnson & JohnsonInvega Sustenna	$178	$32,45314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Roanoke

David ScheidererRoanoke$2.4M
Anita KablingerRoanoke$333K
Ralph McKenzieRoanoke$161K
Roopa SethiRoanoke$49K
Albert AriasRoanoke$20K
Niku SinghFalls Church$2.5M
Kent McDanielGlen Allen$2.1M
Jasdeep MiglaniManassas$958K
Frederick MoellerRichmond$678K
David SpiegelNorfolk$565K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →